These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Author: Alwan S, Bandoli G, Chambers CD.
    Journal: Clin Pharmacol Ther; 2016 Jul; 100(1):34-41. PubMed ID: 27060574.
    Abstract:
    Use of selective serotonin reuptake inhibitors (SSRIs) in late pregnancy has been associated with persistent pulmonary hypertension of the newborn (PPHN), a rare condition with substantial infant mortality and morbidity. Although the increase in absolute risk is small on a population level, it may be of concern to many patients. It remains unclear the extent to which the increased risks reported for PPHN are explained by the underlying maternal illness rather than the use of SSRIs.
    [Abstract] [Full Text] [Related] [New Search]